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Aims
1. To study the efficacy of lower dose GnRHa in pub-
ertal suppression and bone age advancement.
2. To study if low dose of GnRHa avoided the need
for concomitant use of GH therapy while causing ade-
quate pubertal suppression.
Methods
Clinical Records of 17 children (16 girls and 1 boy) were
retrospectively analyzed over a period of 24 months
(Mar 2012 to Mar 2014).
All children satisfied the criteria for precocity based
on clinical features, radiological assessment and GnRHa
stimulation test. All 16 girls had idiopathic precocious
puberty and the only boy had hypothalamic hamartoma.
The mean age of presentation was 6. 9 years.
All children received GnRHa as monthly injection in
an average dose of 190 µgm /kg/month and were regu-
larly followed for evaluation of pubertal suppression,
height gain and Bone age advancement.
Results
Over a 24 month study period, children showed good
pubertal suppression with a comparatively low dose of
GnRHa (190 µgm/kg/month). Mean LH post stimulation
while on therapy was 2.31 miu/ml suggesting adequate
suppression, average annual growth velocity was 5.1 cm.
Advancement in bone age was 1.4 years over a period of
2 years.
Conclusion
1. Children with CPP could be managed with a lower
dose of GnRHa to achieve adequate pubertal suppres-
sion (190 µgm/kg/month as opposed to the standard
recommended dose of 300 - 750 µgm/kg/month).
2. While adequately suppressing puberty and control-
ling bone age advancement, lower dose of GnRHa
seems to allow normal height gain thus negating the
need for concomitant GH therapy in an economically
challenging situation.
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